Cargando…
The Challenges and Opportunities of Pharmacoepidemiology in Bone Diseases
Pharmacoepidemiology is used extensively in osteoporosis research and involves the study of the use and effects of drugs in large numbers of people. Randomized controlled trials are considered the gold standard in assessing treatment efficacy and safety. However, their results can have limited exter...
Autores principales: | Alarkawi, Dunia, Ali, M Sanni, Bliuc, Dana, Center, Jacqueline R, Prieto‐Alhambra, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124176/ https://www.ncbi.nlm.nih.gov/pubmed/30283902 http://dx.doi.org/10.1002/jbm4.10051 |
Ejemplares similares
-
Applying Machine Learning in Distributed Data Networks for Pharmacoepidemiologic and Pharmacovigilance Studies: Opportunities, Challenges, and Considerations
por: Wong, Jenna, et al.
Publicado: (2022) -
Multimorbidity Increases Risk of Osteoporosis Under-Diagnosis and Under-Treatment in Patients at High Fracture Risk: 45 and up a Prospective Population Based-Study
por: Bliuc, Dana, et al.
Publicado: (2021) -
The association between multimorbidity and osteoporosis investigation and treatment in high-risk fracture patients in Australia: A prospective cohort study
por: Bliuc, Dana, et al.
Publicado: (2023) -
Pharmacoepidemiology: An Overview
por: Sabaté, Mònica, et al.
Publicado: (2023) -
Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges
por: Lai, Edward Chia-Cheng, et al.
Publicado: (2018)